Javascript must be enabled to continue!
Improving Pancreatic Islet Transplantation Using Fibrin Hydrogel Containing Microvascular Fragments in Subcutaneous Tissue of Type I Diabetic Rats
View through CrossRef
Abstract
Objective(s): Islet transplantation offers a promising treatment for Type 1 diabetes mellitus (T1DM). Subcutaneous tissue is a non-invasive site, but it has poor blood supply and requires more islets to achieve normoglycemia. We assessed the impact of fibrin hydrogel containing microvascular fragments (MVF) on the vascularization of subcutaneous tissue using two approaches: prevascularization (prior to islet transplantation) or co-transplantation (simultaneously with islet transplantation).
Materials and methods: Wistar rats were prevascularized subcutaneously for 7 days with fibrin (H), 5000 MVF, or fibrin + 5000 MVF (HMVF). After streptozotocin injection to induce T1DM, 1500 islet equivalents (IEQ) were transplanted into prevascularized groups. A co-transplantation group received 1500 IEQ and HMVF (Co-HMVF1500), and a control group received 3000 IEQ alone (Islet only 3000). Graft function was evaluated through blood glucose monitoring, glucose tolerance tests, immunostaining, and plasma insulin concentration over 28 days.
Results: HMVF-prevascularized group presented significantly more CD31-positive cells compared with those from H- or MVF-prevascularized groups (p<0.05). Prevascularization and co-transplantation approaches using HMVF resulted in normoglycemia with a reduced islet mass (1500 IEQ) compared with those in the Islet only3000, H1500, and MVF1500 groups. In addition, both the HMVF1500 and Co-HMVF1500 rats indicated superior islet survival and function, compared with the H1500, MVF1500, and Islet only3000 groups, as evidenced by increased CD31-positive cells and insulin-positive cells, improved glucose tolerance, and elevated plasma insulin concentrations (p<0.05).
Conclusion: Fibrin hydrogel containing MVF could significantly increase the survival and function of subcutaneously transplanted islets, allowing for effective glycemic control with a reduced islet mass.
Springer Science and Business Media LLC
Title: Improving Pancreatic Islet Transplantation Using Fibrin Hydrogel Containing Microvascular Fragments in Subcutaneous Tissue of Type I Diabetic Rats
Description:
Abstract
Objective(s): Islet transplantation offers a promising treatment for Type 1 diabetes mellitus (T1DM).
Subcutaneous tissue is a non-invasive site, but it has poor blood supply and requires more islets to achieve normoglycemia.
We assessed the impact of fibrin hydrogel containing microvascular fragments (MVF) on the vascularization of subcutaneous tissue using two approaches: prevascularization (prior to islet transplantation) or co-transplantation (simultaneously with islet transplantation).
Materials and methods: Wistar rats were prevascularized subcutaneously for 7 days with fibrin (H), 5000 MVF, or fibrin + 5000 MVF (HMVF).
After streptozotocin injection to induce T1DM, 1500 islet equivalents (IEQ) were transplanted into prevascularized groups.
A co-transplantation group received 1500 IEQ and HMVF (Co-HMVF1500), and a control group received 3000 IEQ alone (Islet only 3000).
Graft function was evaluated through blood glucose monitoring, glucose tolerance tests, immunostaining, and plasma insulin concentration over 28 days.
Results: HMVF-prevascularized group presented significantly more CD31-positive cells compared with those from H- or MVF-prevascularized groups (p<0.
05).
Prevascularization and co-transplantation approaches using HMVF resulted in normoglycemia with a reduced islet mass (1500 IEQ) compared with those in the Islet only3000, H1500, and MVF1500 groups.
In addition, both the HMVF1500 and Co-HMVF1500 rats indicated superior islet survival and function, compared with the H1500, MVF1500, and Islet only3000 groups, as evidenced by increased CD31-positive cells and insulin-positive cells, improved glucose tolerance, and elevated plasma insulin concentrations (p<0.
05).
Conclusion: Fibrin hydrogel containing MVF could significantly increase the survival and function of subcutaneously transplanted islets, allowing for effective glycemic control with a reduced islet mass.
Related Results
Progressive Islet Graft Failure Occurs Significantly Earlier in Autoantibody-Positive Than in Autoantibody-Negative IDDM Recipients of Intrahepatic Islet Allografts
Progressive Islet Graft Failure Occurs Significantly Earlier in Autoantibody-Positive Than in Autoantibody-Negative IDDM Recipients of Intrahepatic Islet Allografts
Alloimmunity has been uncovered to be a cause of graft loss representing a major barrier for clinical islet transplantation, and several studies are designed to evaluate new strate...
Pancreatic islet transplantation prevents the impaired healing of intestinal anastomoses in Lewis rats with streptozotocin‐induced diabetes
Pancreatic islet transplantation prevents the impaired healing of intestinal anastomoses in Lewis rats with streptozotocin‐induced diabetes
Pancreatic islet transplantation may prevent secondary complications of diabetes mellitus, but its potential benefits on early complications have been incompletely examined. The ob...
Exosomal-microRNAs Improve Islet Cell Survival and Function In Islet
Transplantation
Exosomal-microRNAs Improve Islet Cell Survival and Function In Islet
Transplantation
Abstract:
Exosomal-microRNAs (Exo-miRNAs) are key regulators of islet cell function, including insulin
expression, processing, and secretion. Exo-miRNAs have a significant impact o...
Current Assessment of Clinical Pancreatic Islet Allotransplantation
Current Assessment of Clinical Pancreatic Islet Allotransplantation
Clinical islet allotransplantation represents a minimally invasive, efficacious alternative to pancreas transplantation for restoring glycemic control and insulin independence in s...
Changes of Islet Size and Islet Size Distribution Resulting from Protein‐Malnutrition in Lean (Fa/Fa) and Obese (fa/fa) Zucker Rats
Changes of Islet Size and Islet Size Distribution Resulting from Protein‐Malnutrition in Lean (Fa/Fa) and Obese (fa/fa) Zucker Rats
AbstractTSE, ELIZABETH O, FRANCINE M GREGOIRE, BRIGITTE REUSENS, CLAUDE REMACLE, JOSEPH J HOET, PATRICIA R JOHNSON, JUDITH S STERN. Changes of islet size and islet size distributio...
Improvement effects of transplanting pancreatic islet that previously incubated with biomaterials on the diabetic nephropathy in STZ- diabetic rats
Improvement effects of transplanting pancreatic islet that previously incubated with biomaterials on the diabetic nephropathy in STZ- diabetic rats
Abstract
Background
Islet transplantation is an effective treatment for diabetes or even its complications. Aim of this study is to investigate effi...
Effects of biomaterial-incubated pancreatic islet transplantation on liver dysfunction of STZ-diabetic rats
Effects of biomaterial-incubated pancreatic islet transplantation on liver dysfunction of STZ-diabetic rats
Abstract
Islet transplantation is one of the potential therapies for diabetes or even its subsequent complications. We aim to scrutinize the effectiveness of biomaterial-cu...


